Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2020

Kahn R, Zhou ZN, Goyal A, Gamble C, Nicholson N, Caputo TA, et al. Is hysterectomy necessary for the treatment of preinvasive stratified mucin producing intraepithelial lesions of the cervix? Int J Gynecol Cancer. 2020;30(9):1298-1302.

Li N, Inoue K, Sun J, Niu Y, Lalani S, Yallowitz A, et al. Osteoclasts are not a source of SLIT3. Bone Res. 2020;8:11.

Fulmer CG, Park K, Dilcher T, Ho M, Mirabelli S, Alperstein S, et al. Next-generation sequencing of residual cytologic fixative preserved DNA from pancreatic lesions: A pilot study. Cancer Cytopathol. 2020;128(11):840-851.

Liang H, Wang Q, Wang D, Zheng H, Kalvakolanu DV, Lu H, et al. RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7. Biochem Pharmacol. 2020;180:114118.

Ramalingam P, Poulos MG, Lazzari E, Gutkin MC, Lopez D, Kloss CC, et al. Chronic activation of endothelial MAPK disrupts hematopoiesis via NFKB dependent inflammatory stress reversible by SCGF. Nat Commun. 2020;11(1):666.

Khorrami M, Bera K, Leo P, Vaidya P, Patil P, Thawani R, et al. Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study. Lung Cancer. 2020;142:90-97.

Nathan C. Resisting antimicrobial resistance. Nat Rev Microbiol. 2020;18(5):259-260.

Ramos JC, Sparano JA, Chadburn A, Reid EG, Ambinder RF, Siegel ER, et al. Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial). Blood. 2020;136(11):1284-1297.

Barone P, DeSimone RA. Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design. Transfusion. 2020;60(6):1123-1127.

Ginter PS, McIntire PJ, Kurtis B, Mirabelli S, Motanagh S, Hoda S, et al. Adenomyoepithelial tumors of the breast: molecular underpinnings of a rare entity. Mod Pathol. 2020;33(9):1764-1772.